Deep Track Capital key facts
- Deep Track Capital is a venture capital firm based in Greenwich, Connecticut with 17 tracked portfolio companies.
- Notable positions include Tubulis, Halda Therapeutics, 35Pharma.
- PrivateMarketView records 1 deal participation by Deep Track Capital.
- Deep Track Capital has 4 funds on record, raising $2.6B across the 2 that report a size.
- The team roster lists 15 people.
- Deep Track Capital reports $5.6B in regulatory assets under management across 2 private funds, per its SEC Form ADV (2026-03).
About Deep Track Capital
Founded in 2020, Deep Track Capital is a venture capital investment firm based in Greenwich, Connecticut. The firm seeks to invest in companies operating in the biotechnology and life sciences sectors. This firm is a Registered Investment Adviser (RIA).
Investment focus
Its SEC Form ADV lists $5.6 billion in regulatory assets under management across 2 private funds (Mar 2026).
Investment activity
Deep Track Capital joined 1 recorded round in the last two years. 1 round landed in the last 90 days. Most recently: Superluminal Medicines (Series B, Sep 2026).
Deep Track Capital portfolio at a glance
17 portfolio companies are on record for Deep Track Capital, including Tubulis, Halda Therapeutics and 35Pharma.
14 of the 17 carry a recorded valuation.
Deep Track Capital funds
4 funds are on record for Deep Track Capital, totalling $2.6 billion across the 2 that report a size. The most recent is Deep Track Special Opportunities Fund, LP (2025 vintage).
Deep Track Capital team
15 people are on record at Deep Track Capital: 7 associates, 3 managing partners, 1 analyst and 4 others. Senior names include Brett Erkman (Managing Director), Gerard Smith (Managing Director) and Rael Mazansky (Managing Director). 15 of them have a verified direct contact on file.
Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.
Deep Track Capital at the SEC
Form ADV · 2026-03 · CRD 312459- Regulatory AUM
- $5.6B
- Private fund assets
- $8.4B
- Private funds
- 2 · 2 hedge
- Staff
- 19
- Registered office
- GREENWICH, CT
- SEC status
- Approved
Reports custody of client assets.
Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as DEEP TRACK CAPITAL, LP).
- ·The top 10 names in the book — of 17 recorded positions
- ·Watchlist + alerts for Deep Track Capital's activity
Portfolio
17 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Tubulis | Drug Discovery | ▮ | ▮ | ▮ |
| Halda Therapeutics | Drug Discovery | ▮ | ▮ | ▮ |
| 35Pharma | — | ▮ | ▮ | ▮ |
+ 14 more companies · all 17, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | ||||
Deep Track Capital recent deals
1 recordedMembership and data by Private Market View
Funds
4 recorded- Deep Track Special Opportunities Fund, LP2025—
- Deep Track Special Opportunities Offshore Fund, LP2025—
- Deep Track Biotechnology Fund, LP2021$842.0M
- Deep Track Biotechnology Offshore Fund, Ltd.2021$1.7B
$2.6B raised across the 2 funds that report a size
Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.
Frequently asked about Deep Track Capital
- What companies does Deep Track Capital invest in?
- Deep Track Capital has 17 recorded portfolio companies, including Tubulis, Halda Therapeutics, 35Pharma.
- What is Deep Track Capital's AUM?
- Deep Track Capital manages approximately $5.2B in assets.